The Swiss Business Hub USA is the New York-based representative of the official international trade and investment promotion agency Switzerland Global Enterprise (S-GE). Part of the Consulate General of Switzerland in New York and with offices in San Francisco, Atlanta and Boston (Cambridge), it is responsible for implementing Swiss export strategies in the US and for promoting Switzerland as a business location. The Swiss Business Hub USA provides localized support, market information, consulting and networking services to Swiss companies venturing into the US market. In addition, the Swiss Business Hub actively promotes Switzerland as a highly attractive business and investment location for US companies looking for growth in Switzerland and in Europe. The Swiss Business Hub proactively contacts and informs US-based companies about the key advantages of Switzerland as a business and investment location. The Swiss Business Hub USA has a first-rate network of contacts both in the US and in Switzerland. | The Swiss Business Hub USA is the New York-based representative of the official international trade and investment promotion agency Switzerland Global Enterprise (S-GE). Part of the Consulate General of Switzerland in New York and with offices in San Francisco, Atlanta and Boston (Cambridge), it is responsible for implementing Swiss export strategies in the US and for promoting Switzerland as a business location.
Illinois Economic Development Corporation
Illinois Economic Development Corporation’s mission is to bring jobs, investment, and economic prosperity to the state of Illinois through dynamic partnerships and collaborations with companies, universities, not-for-profit organizations, and the government to deliver a unified approach to economic development. Formerly known as Intersect Illinois.
GlobalData
GlobalData has decades of experience in being the trusted, gold standard intelligence provider to leading Pharmaceutical brands, manufacturers, and suppliers, helping them to make faster, more informed decisions. | GlobalData is a data and analytics company providing the Life Science Community with Market and Competitive Intelligence. GlobalData serves over 4,000 world’s largest companies with over 600 healthcare analysts by gaining insights into competitors, evaluating market opportunities, and provide strategic opinions in the Pharma/Biotech, CMO/CDMO, CRO, Medical Device/Medtech and Consumer Health industries. From research and development, clinical trials, business developments to investment due diligence, our clients can make better business decisions on our fully integrated one-stop intelligence center platform. | GlobalData’s Construction portfolio offers insights across the entire global construction market, from market-sizing, companies, construction innovations, risks, regulatory developments, M&A, and financial transactions, to projects and project contacts. Our connected Construction Intelligence offers the most comprehensive coverage of construction projects available, tracking new construction projects totaling over US$70tn globally from announcement to completion, by sector, stage, scope, and more. Our industry leading portfolio of brands include Cranes Today, Tunnels & Tunnelling, and World Construction Network amongst others, and have informed the construction landscape since 1969.
FINGERPAINT BRANDING
Fingerpaint Branding, formerly Leaderboard Branding, is a global naming and branding firm that delivers strategic insights and world-class creativity to every client, on every engagement. Built on the tenets of putting people first and taking pride in your work, Fingerpaint Branding has developed strong and strategic partnerships with healthcare, biopharma, consumer, and B2B companies. In the biopharma and healthcare space, Fingerpaint Branding supports clients in the early phases of clinical development. The expert strategists at Fingerpaint Branding have a unique ability to optimize a brand’s commercial potential while mitigating safety concerns and aligning to regulatory guidelines. With expertise in nonproprietary naming, clinical trial branding, global trade name development, and visual design, Fingerpaint Branding provides creative solutions through each phase of the drug development process. Fingerpaint Branding’s drug safety consulting and assessment capabilities help clients make crucial commercial decisions and regulatory submissions with confidence. Connect with us at fingerpaintbranding.com and follow us on LinkedIn. | Fingerpaint Branding is a global naming and branding consultancy delivering one-of-a-kind creativity to every partner. Our commitment to strong, strategic partnerships builds distinctive, memorable brands.
EPS Group
From our beginnings in 1991 as a systems company built on medical statistics, the EPS Group has responded to customer needs amid structural changes in the market and increasingly rigorous and complex drug development. EPS has evolved as a CRO (Contract Research Organization) and expanded our offerings to include SMO (Site Management Organization) and CSO (Contract Sales Organization) services, thereby becoming a comprehensive provider of various support services for the healthcare industry. CRO： In response to requests from pharmaceutical, medical device and regenerative medicine companies, medical institutions, governmental agencies, and others, the EPS CRO Group provides One-Stop Solutions to support the development of pharmaceuticals, medical devices, foods, and cosmetics. SMO： The EPS SMO Group enhances clinical trials by collaboration with medical institutions across Japan, leveraging digital technology to improve efficiency, including the promotion of Decentralized Clinical Trials (DCTs) and the development of remote systems for clinical trial document management. CSO： The EPS CSO provides targeted support to pharmaceutical and medical device manufacturers after product approval. We provide contact center operations, and a range of services from pre-approval to post-marketing stages, employing a skilled workforce to effectively fulfill customer needs. | EPS Holdings, Inc., a Japanese headquartered company, is a comprehensive provider of clinical trial and research outsourced services. EPS Group, with over 7,800 staff, provides quality support to pharmaceutical, biotech, regenerative medicine, and medical device companies. Core businesses are CRO, SMO, Contract Sales Support, and China product development and distribution. EPS operates in Japan, China, South Korea, and Taiwan and, through a partner, supports studies in other Asia-Pacific countries. Looking towards the future, we will strengthen our forward-looking spirit expressed as an “Ever Progressing System.” | The EPS Group was founded in 1991 as a pioneer in the domestic Contract Research Organization (CRO) industry. Since then, we have expanded our diverse services, including Site Management Organization (SMO) and Contract Sales Organization (CSO), with a primary focus on CRO. We provide end-to-end support solutions from the development of pharmaceuticals, medical devices, and regenerative medicine products to post-marketing surveillance. Building on the foundation of our clinical trial and post-marketing businesses, which boast a top-tier scale and proven track record in Japan, we are actively engaging in data business and new ventures, constantly striving for evolution.
Contract Pharma
Contract Pharma is the premier media outlet linking contract service providers and their pharma/biopharma sponsors. Rooted in its legacy print publication—issued 10 times per year—the Contract Pharma brand continues to evolve across its digital media platform through ContractPharma.com and social media channels. Be it through print or digital, Contract Pharma offers a wide variety of products designed to maximize brand exposure and get your message across to the companies and decision makers that matter most. | Contract Pharma is the premier media outlet linking contract service providers and their pharma/biopharma sponsors. Rooted in our legacy print publication—issued 9 times per year—the Contract Pharma brand continues to evolve across its digital media platforms through ContractPharma.com and social media channels. Contract Pharma offers a wide variety of products designed to maximize brand exposure and get your message across to the companies and decision makers that matter most. | Contract Pharma | Connecting Pharma Innovators with Outsourcing Partners Contract Pharma is the leading B2B media brand serving the global pharmaceutical and biopharmaceutical outsourcing marketplace. For more than two decades, we have connected pharma sponsors with CROs, CMOs, and CDMOs that power drug development and manufacturing worldwide. Originally established as a print publication published nine times annually, Contract Pharma has evolved into a fully integrated, multi-platform pharmaceutical media brand. Today, we deliver unmatched reach across print, digital, social media, webinars, industry surveys, custom content programs, and live events. Through ContractPharma.com, we provide authoritative coverage of: Pharmaceutical outsourcing trends Regulatory developments Facility expansions M&A activity Emerging technologies Executive leadership strategy At the Center of Pharmaceutical Industry Transformation The pharmaceutical industry is undergoing rapid change. Advances in AI in drug development, biologics manufacturing, cell and gene therapies, and personalized medicine are reshaping how drugs are discovered, developed, and delivered. Increasing regulatory complexity and global supply chain pressures have made pharmaceutical outsourcing a strategic imperative. As the global contract services market is projected to more than double by 2032, trusted insight and strong industry connections are more valuable than ever. Contract Pharma sits at the center of this evolution — informing decision-makers and connecting partners across the outsourcing ecosystem. A Qualified, Decision-Making Audience Each month, Contract Pharma reaches more than 150,000 qualified professionals across the pharmaceutical supply chain. Integrated Pharmaceutical Marketing That Performs Contract Pharma delivers multi-platform pharmaceutical marketing solutions designed to maximize brand visibility, thought leadership, and lead generation. Print advertising Digital campaigns Sponsored content Industry webinars eNewsletters Industry surveys Targeted lead initiatives 25th Annual Contracting & Outsourcing Conference September 24–25, 2026 Hyatt Regency – New Brunswick, NJ Our flagship live event brings together 400+ pharmaceutical outsourcing professionals for two days of education, networking, and partnership development. The Definitive Media Resource for Pharmaceutical Outsourcing Contract Pharma is more than a publication — it is a strategic growth partner to the global pharmaceutical outsourcing community. Download the Media Kit | Advertise with Contract Pharma | Contact Our Team
BRAND INSTITUTE
Brand Institute is the global leader in brand name and identity development. We provide a broad portfolio of branding and naming-related services, including name development, trademark searches, market research, regulatory services, and visual identity solutions. | Brand Institute is the global leader in brand name and identity development. For over thirty years, we have been providing a broad portfolio of branding and naming-related services, including name development, trademark searches, market research, regulatory services, and visual identity solutions.